haloperidol has been researched along with amantadine in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 57 (64.77) | 18.7374 |
1990's | 6 (6.82) | 18.2507 |
2000's | 13 (14.77) | 29.6817 |
2010's | 10 (11.36) | 24.3611 |
2020's | 2 (2.27) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
Brown, F; Davies, JA; Redfern, PH | 1 |
Lazarova, MB; Roussinov, KS | 2 |
Goldberg, LI | 1 |
West, HH | 1 |
Allen, RM; Flemenbaum, A | 1 |
Gelenberg, AJ; Mandel, MR | 1 |
Costall, B; Naylor, RJ | 2 |
Bariletto, S; Dollar, E; Leitz, F | 1 |
Costall, B; Naylor, RJ; Neumeyer, JL | 1 |
Borzecki, Z; Kaliszuk, S; Swies, Z | 1 |
Amdur, RL; Carvey, PM; Kao, LC; Klawans, HL; Lin, DH; Singh, R; Zhang, TJ | 1 |
Jorgenson, C; Porphyris, H | 1 |
Eviatar, J; Hermesh, H; Sirota, P | 1 |
Dimpfel, W; Koch, R; Schatton, W; Spüler, M | 1 |
Munitz, H; Shalev, A | 1 |
Alperina, E; Cheido, M; Devoino, L; Idova, G; Morozova, N | 1 |
Fujiwara, M; Kiyota, Y; Ohta, H; Sakurai, Y; Shibata, S; Shimazoe, T; Ueki, S | 1 |
Bhalla, S; Mehta, VL; Wafai, ZA | 1 |
Davidson, M; Davis, KL; Powchik, P | 1 |
Teoh, R; Vallance-Owen, J; Woo, J | 1 |
Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 1 |
Ahmed, HH; Fayez, M; Quadri, SK | 1 |
Gilbert, GJ | 3 |
Davies, JA; Redfern, PH | 3 |
Grewaal, DS; McGeer, EG; McGeer, PL | 1 |
Zetler, G | 1 |
Candelise, L; Faglioni, P; Spinnler, H; Vignolo, LA | 1 |
Lahti, RA; McAllister, B; Wozniak, J | 1 |
Kadzielawa, K | 1 |
Barnett, A; Fiore, JW | 1 |
Davies, JA; Jackson, B; Redfern, PH | 1 |
Baran, L; Maj, J; Sarnek, J; Sowińska, H | 1 |
Hitomi, M; Mori, J; Oashi, T; Sato, Y | 1 |
Bigwood, GF | 1 |
Klusha, VE; Kozlovskaia, MM; Svirskis, ShV; Val'dman, AV | 1 |
Borison, RL; Diamond, BI | 1 |
Allen, RM | 1 |
Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
Benay, EM; Klein, MS; Saran, BM | 1 |
Barreira, P; Lipinski, JF; Zubenko, GS | 1 |
Channabasavanna, SM; Desai, NG; Gangadhar, BN | 1 |
Gómez, EA | 1 |
Ang, L; Borison, RL; Davis, JM; Diamond, BI; Hamilton, WJ | 1 |
Borison, RL; Davis, JM | 1 |
Yung, CY | 1 |
Ang, L; Borison, RL; Chang, S; Comaty, JE; Davis, JM; Dysken, M | 1 |
Spoerlein, MT; Vallano, ML; VanderWende, C | 1 |
Kleinrok, Z; Szurska, G | 1 |
Honda, Y; Kagono, Y; Kita, S; Saito, M; Suitsu, N | 1 |
Eshel, Y; Keren, O; Korczyn, AD | 1 |
Allen, RM; Brauchi, JT; Lane, JD | 1 |
Boada, JN; Feria, M; Padron, F | 1 |
Ferraz, MR; Santos, R | 1 |
Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
Agelink, MW; Dammers, S; Leonhardt, M; Schär, V; Zeit, T | 1 |
Guin-Renfroe, S; Meythaler, JM; Wilkinson, R | 1 |
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Lee, J | 1 |
Evangelou, A; Kiortsis, DN; Konitsiotis, S; Tsironis, C | 1 |
Ohmori, T; Yamauchi, K | 1 |
Goto, M; Kawabe, M; Kimura, S; Kon, K; Muneoka, K; Shirayama, Y | 1 |
Gelfius, CD; Mortimer, D; Potts, MA | 1 |
Arandarcikaite, O; Graunaite, I; Lodiene, G; Machiulskiene, V; Pukalskas, A | 1 |
Bernal, JA; Bez, Y; Coffey, BJ; Zaydlin, M | 1 |
4 review(s) available for haloperidol and amantadine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The neuroleptic malignant syndrome: agent and host interaction.
Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome | 1986 |
[The neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benperidol; Combined Modality Therapy; Diagnosis, Differential; Fluid Therapy; Haloperidol; Humans; Male; Methotrimeprazine; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid | 1995 |
[Two cases of tardive Tourette syndrome].
Topics: Adult; Akathisia, Drug-Induced; Alcoholism; Amantadine; Antipsychotic Agents; Cholinergic Antagonists; Dopamine Agents; Dopamine Antagonists; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Sulpiride; Tourette Syndrome | 2006 |
4 trial(s) available for haloperidol and amantadine
Article | Year |
---|---|
Treatment of spasmodic torticollis with amantadine: a double-blind study.
Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Placebos; Torticollis | 1977 |
Letter: Treatment of Huntington's chorea.
Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Clinical Trials as Topic; Diazepam; Dihydroxyphenylalanine; Drug Therapy, Combination; Haloperidol; Humans; Huntington Disease; Hydrazines; Reserpine | 1973 |
Treatment approaches in Gilles de la Tourette syndrome.
Topics: Amantadine; Benztropine; Clonidine; Fluphenazine; Haloperidol; Humans; Lithium; Tourette Syndrome; Trifluoperazine | 1983 |
New pharmacological approaches in the treatment of Tourette syndrome.
Topics: Adolescent; Adult; Amantadine; Benztropine; Child; Clinical Trials as Topic; Clonidine; Female; Fluphenazine; Haloperidol; Humans; Lithium; Male; Tourette Syndrome; Trifluoperazine | 1982 |
80 other study(ies) available for haloperidol and amantadine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
The mechanism of the hypothermic effect of amantadine in rats and mice.
Topics: Amantadine; Animals; Body Temperature; Depression, Chemical; Dextroamphetamine; Drug Interactions; Female; Haloperidol; Male; Mice; Pimozide; Piribedil; Rats; Reserpine; Temperature | 1978 |
On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
Topics: Amantadine; Animals; Apomorphine; Dextroamphetamine; Ditiocarb; Dopamine; Drug Interactions; gamma-Aminobutyric Acid; Haloperidol; Levodopa; Male; Mice; Pentylenetetrazole; Seizures | 1978 |
Comparison of putative dopamine receptors in blood vessels and the central nervous system.
Topics: Amantadine; Amphetamine; Animals; Aporphines; Arteries; Brain; Chlorpromazine; Dogs; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Kidney; Piribedil; Receptors, Drug; Thioridazine; Trifluoperazine; Tyramine | 1975 |
The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Rats; Receptors, Dopamine; Stereotyped Behavior | 1979 |
On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
Topics: Amantadine; Animals; Benserazide; Dextroamphetamine; Dopamine; Drug Interactions; Haloperidol; Levodopa; Male; Mice; Pentylenetetrazole; Rats; Seizures | 1978 |
Catatonic reactions to high-potency neuroleptic drugs.
Topics: Adolescent; Adult; Amantadine; Catatonia; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Parkinson Disease, Secondary; Schizophrenia | 1977 |
A comparison of circling models for the detection of antiparkinson activity.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior; Brain; Dextroamphetamine; Dopamine; Haloperidol; Humans; Isoquinolines; Levodopa; Male; Methylphenidate; Methyltyrosines; Piperazines; Rats; Reserpine; Rotation; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Thalamic Nuclei | 1975 |
Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Catechols; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Methyltyrosines; Rats; Tritium; Tyrosine | 1975 |
Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
Topics: Amantadine; Animals; Aporphines; Behavior; Brain; Dopamine; Extrapyramidal Tracts; Haloperidol; Humans; Limbic System; Male; Methyltyrosines; Rats; Reserpine; Stereotyped Behavior; Substantia Nigra | 1975 |
The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period.
Topics: Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Ethanol; Haloperidol; Male; Metoclopramide; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sulpiride | 1990 |
Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Lithium; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Scopolamine; Stereotyped Behavior; Thioridazine | 1990 |
Idiopathic spasmodic torticollis.
Topics: Amantadine; Biofeedback, Psychology; Follow-Up Studies; Haloperidol; Humans; Methods; Perioperative Nursing; Posture; Torticollis; Transcutaneous Electric Nerve Stimulation | 1985 |
Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine.
Topics: Aged; Amantadine; Dementia; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Recurrence; Substance Withdrawal Syndrome | 1989 |
Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Animals; Benzazepines; Brain; Corpus Striatum; Electroencephalography; Ergolines; Evoked Potentials; Frontal Lobe; Haloperidol; Hippocampus; Male; Memantine; Quinpirole; Rats; Rats, Inbred F344; Receptors, Dopamine; Reticular Formation; Synaptic Transmission; Telemetry | 1987 |
Monoamines as immunomodulators: importance of suppressors and helpers of the bone marrow.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Apomorphine; Biogenic Amines; Bone Marrow; Dopamine; Haloperidol; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred CBA; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1986 |
[Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Catalepsy; Central Nervous System; Dronabinol; Haloperidol; Humans; Male; Methamphetamine; Mice; Motor Activity; Predatory Behavior; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1985 |
Attenuation of pentylenetetrazol kindling of epileptogenesis in rats by dopaminergic agents.
Topics: Amantadine; Amphetamine; Animals; Epilepsy; Haloperidol; Kindling, Neurologic; Levodopa; Male; Metoclopramide; Pentylenetetrazole; Rats | 1988 |
Pisa syndrome in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amantadine; Drug Therapy, Combination; Dystonia; Haloperidol; Humans; Male; Syndrome | 1988 |
Neuroleptic malignant syndrome successfully treated with amantidine.
Topics: Adult; Amantadine; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome | 1986 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Inhibition of plasma prolactin in the rat by amantadine.
Topics: 5-Hydroxytryptophan; Amantadine; Animals; Dose-Response Relationship, Drug; Haloperidol; Male; Prolactin; Rats; Rats, Inbred Strains | 1985 |
Haloperidol in spasmodic torticollis.
Topics: Amantadine; Haloperidol; Humans; Torticollis | 1972 |
A note on the effect of amantadine on body temperature in mice.
Topics: Amantadine; Animals; Body Temperature; Body Temperature Regulation; Dopamine; Female; Haloperidol; Hypothermia, Induced; Methyltyrosines; Mice | 1973 |
Proceedings: The effect of dopamine-antagonists and amantadine on the acquisition of the conditioned avoidance response in rats.
Topics: Amantadine; Animals; Avoidance Learning; Conditioning, Classical; Dopamine Antagonists; Haloperidol; Male; Pimozide; Rats | 1973 |
Influence of noncholinergic drugs on rat striatal acetylcholine levels.
Topics: Acetylcholine; Acetylcholinesterase; Acetyltransferases; Amantadine; Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Biological Assay; Brain Chemistry; Choline; Corpus Striatum; Depression, Chemical; Haloperidol; Levodopa; Male; Methamphetamine; Rats; Rats, Inbred Strains; Reserpine; Stimulation, Chemical; Tyrosine 3-Monooxygenase | 1974 |
Anticataleptic actions of amantadine hydrochloride.
Topics: Amantadine; Animals; Aporphines; Body Temperature; Catalepsy; Central Nervous System; Drug Antagonism; Haloperidol; Humans; Male; Mice; Nicotine; Nitrophenols; Phosphates; Pilocarpine; Tetrabenazine; Trifluoperazine | 1970 |
Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Dioxoles; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Humans; Injections; Male; Methylphenidate; Motor Activity; Nialamide; Piperazines; Pyrimidines; Rats; Stereotyped Behavior; Sulfites | 1974 |
Apomorphine antagonism of the elevation of homovanillic acid induced by antipsychotic drugs.
Topics: Amantadine; Animals; Apomorphine; Brain; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; Haloperidol; Homovanillic Acid; Mice; Morphine; Phenylacetates; Receptors, Adrenergic; Structure-Activity Relationship; Synaptic Transmission; Thiothixene; Tranquilizing Agents; Trifluoperazine | 1972 |
The interaction of dopamine-antagonists and amantadine hydrochloride on the acquisition of the conditioned avoidance response in rats.
Topics: Amantadine; Animals; Avoidance Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Pimozide; Rats | 1974 |
Dopamine receptor in the reward system of the rat.
Topics: Amantadine; Animals; Apomorphine; Benzyl Compounds; Cortical Synchronization; Desipramine; Dihydroxyphenylalanine; Dopamine; Electrodes, Implanted; Electroencephalography; Haloperidol; Hydrazines; Hypothalamus; Levodopa; Male; Rats; Receptors, Drug; Reward; Self Stimulation; Time Factors | 1974 |
The effect of antiparkinson drugs on the liguomandibular reflex in cats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Cats; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Haloperidol; Lingual Nerve; Mandibular Nerve; Phenoxybenzamine; Receptors, Drug; Reflex | 1973 |
The effect of anti-Parkinsonian drugs on haloperidol-induced inhibition of the conditioned-avoidance response in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Avoidance Learning; Benzilates; Conditioning, Psychological; Ethylamines; Haloperidol; Male; Propylamines; Rats; Receptors, Adrenergic; Time Factors | 1973 |
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
Topics: Amantadine; Animals; Apomorphine; Blood Pressure; Body Temperature; Brain Chemistry; Catalepsy; Chlorpromazine; Dextroamphetamine; Disulfides; Dopamine; Female; Fluphenazine; Haloperidol; Humans; Imidazoles; Male; Methyltyrosines; Motor Activity; Norepinephrine; Oxotremorine; Parasympatholytics; Rats; Reflex; Reserpine; Spiro Compounds; Stereotyped Behavior | 1974 |
[Pharmacological study of amantadine, a new antiparkinson drug].
Topics: Amantadine; Amines; Animals; Antiparkinson Agents; Avoidance Learning; Brain; Catatonia; Dopamine; Drug Synergism; Haloperidol; Humans; Iris; Male; Methamphetamine; Mice; Movement; Oxotremorine; Perphenazine; Rats; Synaptosomes; Tremor; Tremorine | 1974 |
Treatment of spasmodic torticollis.
Topics: Adult; Aged; Amantadine; Female; Haloperidol; Humans; Male; Middle Aged; Spasm; Torticollis | 1972 |
The medical treatment of spasmodic torticollis.
Topics: Adult; Aged; Amantadine; Electromyography; Female; Follow-Up Studies; Haloperidol; Humans; Hyperthyroidism; Male; Middle Aged; Torticollis | 1972 |
Spasmodic torticollis treated effectively by medical means.
Topics: Aged; Amantadine; Electromyography; Female; Graves Disease; Haloperidol; Humans; Hyperthyroidism; Iodine Isotopes; Male; Middle Aged; Torticollis | 1971 |
[Psychopharmacologic spectrum of melanostatin].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Biogenic Amines; Brain Chemistry; Catalepsy; Cats; Depression; Emotions; Fever; Haloperidol; Humans; Levodopa; Motor Activity; MSH Release-Inhibiting Hormone; Reserpine | 1980 |
Anticholinergics promote neuroleptic-induced tardive dyskinesia.
Topics: Amantadine; Animals; Antipsychotic Agents; Benztropine; Dextroamphetamine; Drug Synergism; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Motor Activity; Parasympatholytics; Rats; Stereotyped Behavior | 1980 |
Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
Topics: Adult; Aged; Amantadine; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Neurocognitive Disorders; Palliative Care; Schizophrenia; Schizophrenia, Paranoid; Thioridazine | 1982 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Clinical evaluation of amantadine and haloperidol in Huntington's chorea.
Topics: Amantadine; Drug Therapy, Combination; Haloperidol; Humans; Huntington Disease; Male | 1980 |
Development of tolerance to the therapeutic effect of amantadine on akathisia.
Topics: Adult; Akathisia, Drug-Induced; Amantadine; Bipolar Disorder; Drug Tolerance; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Parkinson Disease, Secondary; Psychomotor Agitation | 1984 |
Amantadine in the neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Basal Ganglia Diseases; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia | 1984 |
[Extrapyramidal reactions and neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Basal Ganglia Diseases; Dantrolene; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary | 1984 |
Amantadine in Tourette syndrome.
Topics: Adolescent; Adult; Amantadine; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Tourette Syndrome | 1983 |
Case vignettes of movement disorders.
Topics: Adult; Amantadine; Brain Injuries; Clonazepam; Diagnosis, Differential; Dystonia; Female; Haloperidol; Humans; Male; Movement Disorders; Pregnancy; Promethazine; Tic Disorders | 1983 |
Morphine enhances high-affinity choline uptake in mouse striatum.
Topics: Amantadine; Animals; Behavior, Animal; Choline; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Haloperidol; Male; Mice; Morphine; Sodium | 1982 |
[Effect of the stimulators and inhibitors of the central dopaminergic structures on the kininogen level and kallikrein activity in the rat plasma].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Chlorpromazine; Haloperidol; Kallikreins; Kininogens; Male; Rats; Receptors, Dopamine; Reserpine | 1980 |
Computerized EEG study on drug-induced extrapyramidalism in schizophrenic patients.
Topics: Adolescent; Amantadine; Brain; Computers; Electroencephalography; Female; Glycolates; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Pyramidal Tracts; Reference Values; Schizophrenia; Thiophenes; Trihexyphenidyl | 1982 |
Effect of amantadine on pupillary diameter in mice.
Topics: alpha-Methyltyrosine; Amantadine; Animals; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Male; Methyltyrosines; Mice; Mice, Inbred ICR; Mydriatics; Phentolamine; Pupil; Reserpine | 1982 |
Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Haloperidol; Humans; In Vitro Techniques; Kinetics; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior | 1980 |
Respiratory effects of amantadine and bromocriptine and their interaction with haloperidol in anesthetized rats.
Topics: Amantadine; Anesthesia; Animals; Bromocriptine; Drug Interactions; Haloperidol; Male; Rats; Respiration; Time Factors | 1980 |
Amantadine stimulates sexual behavior in male rats.
Topics: Amantadine; Animals; Atropine; Copulation; Cordotomy; Ejaculation; Haloperidol; Male; Penile Erection; Rats; Rats, Wistar; Sexual Behavior, Animal; Stimulation, Chemical | 1995 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |
Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury.
Topics: Adolescent; Amantadine; Brain Injuries; Dopamine Agents; Dopamine Antagonists; Fever; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Propranolol; Treatment Outcome; Vasodilator Agents | 1999 |
A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amantadine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Haloperidol; Idazoxan; Levodopa; Male; Motor Activity; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reserpine | 2005 |
Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias.
Topics: Allosteric Regulation; Amantadine; Animals; Antipsychotic Agents; Dextrorphan; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Male; Phenols; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2006 |
Improvement of mutism in a catatonic schizophrenia case by add-on treatment with amantadine.
Topics: Amantadine; Antiparkinson Agents; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Mutism; Schizophrenia, Catatonic | 2010 |
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Psychomotor Disorders | 2013 |
Leachables and cytotoxicity of root canal sealers.
Topics: Amantadine; Animals; Benzhydryl Compounds; Caproates; Cell Line; Chromatography, Liquid; Composite Resins; Epoxy Compounds; Epoxy Resins; Ethanolamines; In Vitro Techniques; Lactones; Macrophages; Materials Testing; Mice; Microscopy, Fluorescence; Root Canal Filling Materials; Tandem Mass Spectrometry | 2018 |
Improved Treatment Outcome with Haloperidol Decanoate and Amantadine in an Adolescent with Schizoaffective Disorder.
Topics: Adolescent; Amantadine; Antipsychotic Agents; Haloperidol; Humans; Psychotic Disorders; Treatment Outcome | 2023 |